| 000 | 00989 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250516212824.0 | ||
| 264 | 0 | _c20150209 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1479-6821 | ||
| 024 | 7 |
_a10.1530/ERC-13-0165 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLabrie, Fernand | |
| 245 | 0 | 0 |
_aGnRH agonists and the rapidly increasing use of combined androgen blockade in prostate cancer. _h[electronic resource] |
| 260 |
_bEndocrine-related cancer _cAug 2014 |
||
| 300 |
_aR301-17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAndrogen Antagonists _xtherapeutic use |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCastration |
| 650 | 0 | 4 |
_aGonadotropin-Releasing Hormone _xagonists |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 773 | 0 |
_tEndocrine-related cancer _gvol. 21 _gno. 4 _gp. R301-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1530/ERC-13-0165 _zAvailable from publisher's website |
| 999 |
_c23823381 _d23823381 |
||